Sarah McMahon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sarah McMahon has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Qiming Duan
Gladstone Institutes, San Francisco, CA 94158, USA
3 shared publications - Rolf Renne
University of Florida
3 shared publications - Saptarsi M. Haldar
Amgen Research, South San Francisco, California, USA
3 shared publications - Ritu Shekhar
Department of Molecular Genetics and Microbiology University of Florida Gainesville Florida USA
2 shared publications Aarathi Sahadevan
Institute for Transformative Molecular Medicine and Department of Medicine, Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA
1 shared publicationAlexander M Ishov
University of Florida
1 shared publication
Latest Publications
- Open Access
Non-canonical histone H3.3 and its chaperones HIRA and DAXX participate in the regulation of KSHV latency
Kaposi's sarcoma-associated herpesvirus (KSHV), also named HHV-8, is the etiological agent of Kaposi sarcoma (KS), Primary effusion lymphoma (PEL), and Multicentric Castleman's disease. After de novo infection, KSHV genomes rapidly circularize and acquire a chromatin state that favors latency. During latency, the KSHV episome is decorated with distinct epigenetic marks that segregate the viral genome into transcriptionally active and repressed domains, enabling persistent silencing of lytic genes while retaining the capacity for reactivation. Transcription activity of chromatin is regulated at multiple levels, including the incorporation of histone variants such as H3.3, by a specific set of histone chaperones such as HIRA and DAXX. The interaction between LANA and these interphase active chaperones suggests that H3.3 deposition is a critical driver of early chromatinization and the long-term stability of KSHV latency. We detected rapid H3.3 deposition on KSHV episomes and on episomes within long-term infected cells. Moreover, we demonstrated that genetically disrupting the host H3.3 chaperone HIRA pathway by CRISPR/Cas9-mediated knockout impacted the regulation of LANA and maintenance of viral latency that was not altered in DAXX knockout cells. Collectively, these results support a role for HIRA-mediated H3.3 deposition in the regulation of KSHV latency.
Open AccessNon-canonical histone H3.3 and its chaperones HIRA and DAXX participate in the regulation of KSHV latency
Kaposi's sarcoma-associated herpesvirus (KSHV), also named HHV-8, is the etiological agent of Kaposi sarcoma (KS), Primary effusion lymphoma (PEL), and Multicentric Castleman's disease. After de novo infection, KSHV genomes rapidly circularize and acquire a chromatin state that favors latency. During latency, the KSHV episome is decorated with distinct epigenetic marks that segregate the viral genome into transcriptionally active and repressed domains, enabling persistent silencing of lytic genes while retaining the capacity for reactivation. Transcription activity of chromatin is regulated at multiple levels, including the incorporation of histone variants such as H3.3, by a specific set of histone chaperones such as HIRA and DAXX. The interaction between LANA and these interphase active chaperones suggests that H3.3 deposition is a critical driver of early chromatinization and the long-term stability of KSHV latency. We detected rapid H3.3 deposition on KSHV episomes and on episomes within long-term infected cells. Moreover, we demonstrated that genetically disrupting the host H3.3 chaperone HIRA pathway by CRISPR/Cas9-mediated knockout impacted the regulation of LANA and maintenance of viral latency that was not altered in DAXX knockout cells. Collectively, these results support a role for HIRA-mediated H3.3 deposition in the regulation of KSHV latency.
- Open Access
- 16 January 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (1) , e70802
Cross‐Species Insights Into Gamma Herpesvirus Transcriptomes: Long‐Read and Multi‐Omics Perspectives
Comparative transcriptome analyses of gamma herpesviruses have been revolutionized by long‐read sequencing and integrative multi‐omics approaches, enabling unprecedented resolution of viral gene expression. Cross‐species studies of Kaposi's sarcoma‐associated herpesvirus (KSHV), Epstein–Barr virus (EBV), and murine gamma herpesvirus 68 (MHV68) have uncovered a vast diversity of transcript isoforms, including alternative 5′/3′ UTR variants, alternative splice isoforms, and transcripts encoding truncated or extended coding sequences. These efforts revealed novel transcript isoforms harboring partial open reading frames, entirely new ORFs, and an expanding repertoire of viral non‐coding RNAs. Additional regulatory mechanisms, such as promoter dependence on viral replication factors, selective polyadenylation site usage, frameshifting via alternative splicing, and extensive readthrough transcription, further illustrate the complex strategies governing gamma herpesvirus transcriptomes. This review synthesizes these discoveries, highlighting transcriptional strategies employed by gamma herpesviruses for persistence through different phases of replication, while outlining how integrative transcriptomics has reshaped our understanding of herpesvirus gene regulation.
- 16 January 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (1) , e70802
Open AccessCross‐Species Insights Into Gamma Herpesvirus Transcriptomes: Long‐Read and Multi‐Omics Perspectives
Comparative transcriptome analyses of gamma herpesviruses have been revolutionized by long‐read sequencing and integrative multi‐omics approaches, enabling unprecedented resolution of viral gene expression. Cross‐species studies of Kaposi's sarcoma‐associated herpesvirus (KSHV), Epstein–Barr virus (EBV), and murine gamma herpesvirus 68 (MHV68) have uncovered a vast diversity of transcript isoforms, including alternative 5′/3′ UTR variants, alternative splice isoforms, and transcripts encoding truncated or extended coding sequences. These efforts revealed novel transcript isoforms harboring partial open reading frames, entirely new ORFs, and an expanding repertoire of viral non‐coding RNAs. Additional regulatory mechanisms, such as promoter dependence on viral replication factors, selective polyadenylation site usage, frameshifting via alternative splicing, and extensive readthrough transcription, further illustrate the complex strategies governing gamma herpesvirus transcriptomes. This review synthesizes these discoveries, highlighting transcriptional strategies employed by gamma herpesviruses for persistence through different phases of replication, while outlining how integrative transcriptomics has reshaped our understanding of herpesvirus gene regulation.
- Open Access
- 22 December 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (12) , e70765
Targeted Protein Degradation of the Latency‐Associated Nuclear Antigen Evicts Kaposi Sarcoma‐Associated Herpesvirus Episomes From Infected Cells In Vitro
Kaposi sarcoma‐associated herpesvirus (KSHV), a gamma‐herpesvirus, is the main etiological agent of several tumors, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL). The large, double‐stranded viral genome of KSHV is maintained as a latent episome in the nucleus of host cells, where a small subset of viral genes is expressed that facilitate evasion of immune responses and promotion of cell survival and proliferation supporting tumorigenesis. The major latency‐associated nuclear antigen (LANA) is an essential viral factor that is required for genome replication and segregation to maintain viral genomes within dividing cells. Given the essential role of LANA to maintain viral latency, efforts have focused on targeting LANA's role in replication and segregation as a mechanism to overcome latency and tumorigenesis. However, given the complexity in small molecule targeting to DNA‐binding domains, current efforts focused on drugging LANA continue to reach potency milestones for clinical trials. Here, we developed a HaloTag‐based PROTAC model as a proof‐of‐concept for targeted LANA protein degradation. Our findings highlight the power of a PROTAC‐based strategy on eliminating LANA and viral persistence in tissue culture demonstrating promise in the on‐going challenge for targeting this major viral factor in KSHV latency.
- 22 December 2025
- Published by Wiley in Journal of Medical Virology
- Vol. 97 (12) , e70765
Open AccessTargeted Protein Degradation of the Latency‐Associated Nuclear Antigen Evicts Kaposi Sarcoma‐Associated Herpesvirus Episomes From Infected Cells In Vitro
Kaposi sarcoma‐associated herpesvirus (KSHV), a gamma‐herpesvirus, is the main etiological agent of several tumors, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL). The large, double‐stranded viral genome of KSHV is maintained as a latent episome in the nucleus of host cells, where a small subset of viral genes is expressed that facilitate evasion of immune responses and promotion of cell survival and proliferation supporting tumorigenesis. The major latency‐associated nuclear antigen (LANA) is an essential viral factor that is required for genome replication and segregation to maintain viral genomes within dividing cells. Given the essential role of LANA to maintain viral latency, efforts have focused on targeting LANA's role in replication and segregation as a mechanism to overcome latency and tumorigenesis. However, given the complexity in small molecule targeting to DNA‐binding domains, current efforts focused on drugging LANA continue to reach potency milestones for clinical trials. Here, we developed a HaloTag‐based PROTAC model as a proof‐of‐concept for targeted LANA protein degradation. Our findings highlight the power of a PROTAC‐based strategy on eliminating LANA and viral persistence in tissue culture demonstrating promise in the on‐going challenge for targeting this major viral factor in KSHV latency.
- Open Access
- 11 March 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (10) , eabj2917
KLF15 cistromes reveal a hepatocyte pathway governing plasma corticosteroid transport and systemic inflammation
Circulating corticosteroids orchestrate stress adaptation, including inhibition of inflammation. While pathways governing corticosteroid biosynthesis and intracellular signaling are well understood, less is known about mechanisms controlling plasma corticosteroid transport. Here, we show that hepatocyte KLF15 (Kruppel-like factor 15) controls plasma corticosteroid transport and inflammatory responses through direct transcriptional activation of Serpina6 , which encodes corticosteroid-binding globulin (CBG). Klf15 -deficient mice have profoundly low CBG, reduced plasma corticosteroid binding capacity, and heightened mortality during inflammatory stress. These defects are completely rescued by reconstituting CBG, supporting that KLF15 works primarily through CBG to control plasma corticosterone homeostasis. To understand transcriptional mechanisms, we generated the first KLF15 cistromes using newly engineered Klf15 3xFLAG mice. Unexpectedly, liver KLF15 is predominantly promoter enriched, including Serpina6 , where it binds a palindromic GC-rich motif, opens chromatin, and transactivates genes with minimal associated direct gene repression. Overall, we provide critical mechanistic insight into KLF15 function and identify a hepatocyte-intrinsic transcriptional module that potently regulates systemic corticosteroid transport and inflammation.
- 11 March 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 8 (10) , eabj2917
Open AccessKLF15 cistromes reveal a hepatocyte pathway governing plasma corticosteroid transport and systemic inflammation
Circulating corticosteroids orchestrate stress adaptation, including inhibition of inflammation. While pathways governing corticosteroid biosynthesis and intracellular signaling are well understood, less is known about mechanisms controlling plasma corticosteroid transport. Here, we show that hepatocyte KLF15 (Kruppel-like factor 15) controls plasma corticosteroid transport and inflammatory responses through direct transcriptional activation of Serpina6 , which encodes corticosteroid-binding globulin (CBG). Klf15 -deficient mice have profoundly low CBG, reduced plasma corticosteroid binding capacity, and heightened mortality during inflammatory stress. These defects are completely rescued by reconstituting CBG, supporting that KLF15 works primarily through CBG to control plasma corticosterone homeostasis. To understand transcriptional mechanisms, we generated the first KLF15 cistromes using newly engineered Klf15 3xFLAG mice. Unexpectedly, liver KLF15 is predominantly promoter enriched, including Serpina6 , where it binds a palindromic GC-rich motif, opens chromatin, and transactivates genes with minimal associated direct gene repression. Overall, we provide critical mechanistic insight into KLF15 function and identify a hepatocyte-intrinsic transcriptional module that potently regulates systemic corticosteroid transport and inflammation.
- 1 June 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (6) , 2966-2977
Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling
Salt-inducible kinases (SIKs) are key regulators of cellular metabolism and growth, but their role in cardiomyocyte plasticity and heart failure pathogenesis remains unknown. Here, we showed that loss of SIK1 kinase activity protected against adverse cardiac remodeling and heart failure pathogenesis in rodent models and cardiomyocytes derived from human induced pluripotent stem cells. We found that SIK1 phosphorylated and stabilized histone deacetylase 7 (HDAC7) protein during cardiac stress, an event that is required for pathologic cardiomyocyte remodeling. Gain- and loss-of-function studies of HDAC7 in cultured cardiomyocytes implicated HDAC7 as a prohypertrophic signaling effector that can induce c-Myc expression, indicating a functional departure from the canonical MEF2 corepressor function of class IIa HDACs. Taken together, our findings reveal what we believe to be a previously unrecognized role for a SIK1/HDAC7 axis in regulating cardiac stress responses and implicate this pathway as a potential target in human heart failure.
- 1 June 2020
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (6) , 2966-2977
Salt-inducible kinase 1 maintains HDAC7 stability to promote pathologic cardiac remodeling
Salt-inducible kinases (SIKs) are key regulators of cellular metabolism and growth, but their role in cardiomyocyte plasticity and heart failure pathogenesis remains unknown. Here, we showed that loss of SIK1 kinase activity protected against adverse cardiac remodeling and heart failure pathogenesis in rodent models and cardiomyocytes derived from human induced pluripotent stem cells. We found that SIK1 phosphorylated and stabilized histone deacetylase 7 (HDAC7) protein during cardiac stress, an event that is required for pathologic cardiomyocyte remodeling. Gain- and loss-of-function studies of HDAC7 in cultured cardiomyocytes implicated HDAC7 as a prohypertrophic signaling effector that can induce c-Myc expression, indicating a functional departure from the canonical MEF2 corepressor function of class IIa HDACs. Taken together, our findings reveal what we believe to be a previously unrecognized role for a SIK1/HDAC7 axis in regulating cardiac stress responses and implicate this pathway as a potential target in human heart failure.
- 14 March 2020
- Published by Taylor & Francis in Transcription
- Vol. 11 (2) , 66-82
A combinatorial view of old and new RNA polymerase II modifications
The production of mRNA is a dynamic process that is highly regulated by reversible post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II. The CTD is a highly repetitive domain consisting mostly of the consensus heptad sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Phosphorylation of serine residues within this repeat sequence is well studied, but modifications of all residues have been described. Here, we focus on integrating newly identified and lesser-studied CTD post-translational modifications into the existing framework. We also review the growing body of work demonstrating crosstalk between different CTD modifications and the functional consequences of such crosstalk on the dynamics of transcriptional regulation.
- 14 March 2020
- Published by Taylor & Francis in Transcription
- Vol. 11 (2) , 66-82
A combinatorial view of old and new RNA polymerase II modifications
The production of mRNA is a dynamic process that is highly regulated by reversible post-translational modifications of the C-terminal domain (CTD) of RNA polymerase II. The CTD is a highly repetitive domain consisting mostly of the consensus heptad sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. Phosphorylation of serine residues within this repeat sequence is well studied, but modifications of all residues have been described. Here, we focus on integrating newly identified and lesser-studied CTD post-translational modifications into the existing framework. We also review the growing body of work demonstrating crosstalk between different CTD modifications and the functional consequences of such crosstalk on the dynamics of transcriptional regulation.
- Top Cited Papers
- 17 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (390)
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
BET bromodomain inhibition treats heart failure by blocking innate inflammatory and profibrotic gene networks.
- 17 May 2017
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (390)
Top Cited PapersBET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
BET bromodomain inhibition treats heart failure by blocking innate inflammatory and profibrotic gene networks.